10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 21, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 9:00 a.m. Pacific Time.
Related news for (TXG)
- CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
- 10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
- 10x Genomics to Acquire Scale Biosciences
- 10x Genomics Reports Second Quarter 2025 Financial Results
- 10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025